Ginsenosides, potential TMPRSS2 inhibitors, a trade-off between the therapeutic combination for anti-PD-1 immunotherapy and the treatment of COVID-19 infection of LUAD patients
Article in Frontiers in Pharmacology (March 2023)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (March 2023)
Article in Journal of Ethnopharmacology (December 2022)
Article in Phytomedicine (May 2022)